xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

154

KUANetal.

TABLE XVI.9 Evidence surrounding surveillance of IP.

Clinical endpoints

Study

Year LOE Study design Study groups

Conclusion

Sbrana et al. 644

Recurrences (34.09% [15/44]) were observed up to 10 years postoperatively (mean 24.6 months), indicating need for prolonged follow-up

1. Recurrence 2. Time to recurrence 3. Malignant transforma tion

2021

4

Retrospective case series

Patients diagnosed with sinonasal papilloma undergoing ESS with or without open approach ( n = 69; n = 49with IP) Patients diagnosed with primary IP undergoing EEA resection ( n = 102)

Binz et al. 739

2021

4

Retrospective case series

Recurrence

Long-term follow-up is important due to documented cases of recurrences more than 5 years following index surgery (20.0% [2/10] of recurrences) 18 FDG uptake on PET/CT imaging may represent a helpful adjunctive tool to determine presence of recurrent IP for patients in whom recurrence is suspected Close, long-term follow-up is necessary for early detection of recurrence (mean time to recurrence of 41 months) and successful surgical salvage Long-term endoscopic follow-up for surveillance of recurrence following IP resection is imperative (mean time to recurrence of 23 months) MRI may represent the most effective imaging modality for IP recurrence detection (mean time to recurrence 43 months) relative to CT and endoscopic exams and should be considered for

Allegra et al. 743

2010 4

Retrospective case series

Patients with concern for primary or

Recurrence

recurrent IP undergoing preoperative

18 FDG-PET/CT imaging ( n = 12)

Díaz Molina et al. 736

2009 4

Retrospective case series

Patients undergoing

1. Recurrence 2. Time to recurrence

endoscopic, open, or combined resection for IP ( n = 61)

Woodworth et al. 721

1. Recurrence 2. Time to recurrence

2007 4

Retrospective case series

Patients undergoing endoscopic or

endoscopic-assisted open resection for IP ( n = 114)

Petit et al. 741

2000 4

Retrospective case series

Patients diagnosed with recurrent IP ( n = 10)

1. Recurrence 2. Time to recurrence

surveillance, particularly when the area cannot be adequately assessed with endoscopy Abbreviations: CT, computed tomography; EEA, endoscopic endonasal approach; ESS, endoscopic sinus surgery; FDG, fluorodeoxyglucose F 18 ( 18 F-FDG); IP, inverted papilloma; MRI, magnetic resonance imaging; PET, positron emission tomography.

XVII BENIGN VASCULAR NEOPLASMS AND LESIONS A Juvenile nasopharyngeal angiofibroma

Policy level Recommendation. Intervention Recommend identification of evidence-based risk factors that will increase risk of recurrence for IP and prolonged follow-up for surveillance of IP patients due to

propensity for delayed recurrence. Close clinical follow-up for all patients due to risk for recurrence even after 5 years.

JNA is a benign but locally destructive, highly vascu lar lesion that typically affects adolescent males. 767 JNA accounts for approximately 0.5% of head and neck tumors with an incidence of about 1 in 150,000. 6,768 The most